Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Nelson

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Rand Health Quarterly|January 14, 2017
CMS Innovation Center Health Care Innovation Awards: Evaluation PlanSandra H Berry, Thomas W Concannon, Kristy Gonzalez Morganti, et al.
Cell Reports Methods|April 27, 2022
Improved integration of single-cell transcriptome and surface protein expression by LinQ-ViewLei Li, Haley L Dugan, Christopher T Stamper, et al.
Journal of Visualized Experiments : Jove|May 1, 2018
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning SystemLaurence E Court, Kelly Kisling, Rachel McCarroll, et al.
Bioconjugate Chemistry|February 27, 2018
Modulating Antibody-Drug Conjugate Payload Metabolism by Conjugation Site and Linker ModificationDian Su, Katherine R Kozak, Jack Sadowsky, et al.
Cancer Research|March 5, 2009
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selectionAndrew G Polson, Jill Calemine-Fenaux, Pamela Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preferenceGunter Schumann, Chunyu Liu, Paul O'Reilly, et al.
BMJ (Clinical Research Ed.)|December 11, 2013
Children must be protected from the tobacco industry's marketing tacticsNicholas Hopkinson, Colin Wallis, Bernard Higgins, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Rand Health Quarterly|January 14, 2017
CMS Innovation Center Health Care Innovation Awards: Evaluation PlanSandra H Berry, Thomas W Concannon, Kristy Gonzalez Morganti, et al.
Cell Reports Methods|April 27, 2022
Improved integration of single-cell transcriptome and surface protein expression by LinQ-ViewLei Li, Haley L Dugan, Christopher T Stamper, et al.
Journal of Visualized Experiments : Jove|May 1, 2018
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning SystemLaurence E Court, Kelly Kisling, Rachel McCarroll, et al.
Bioconjugate Chemistry|February 27, 2018
Modulating Antibody-Drug Conjugate Payload Metabolism by Conjugation Site and Linker ModificationDian Su, Katherine R Kozak, Jack Sadowsky, et al.
Cancer Research|March 5, 2009
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selectionAndrew G Polson, Jill Calemine-Fenaux, Pamela Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preferenceGunter Schumann, Chunyu Liu, Paul O'Reilly, et al.
BMJ (Clinical Research Ed.)|December 11, 2013
Children must be protected from the tobacco industry's marketing tacticsNicholas Hopkinson, Colin Wallis, Bernard Higgins, et al.
Pageof 11